Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines

Curr HIV/AIDS Rep. 2022 Oct;19(5):328-343. doi: 10.1007/s11904-022-00622-0. Epub 2022 Sep 17.

Abstract

Background: The discovery of vaccines significantly reduced morbidity and mortality of infectious diseases and led to the elimination and eradication of some. Development of safe and effective vaccines is a critical step to the control of infectious diseases; however, there is the need to address vaccine hesitancy because of its potential impact on vaccine uptake.

Methods: We conducted a narrative review of studies on interventions to address measles and human papillomavirus vaccine hesitancy. We discussed how lessons learned from these studies could be applied towards COVID-19 and future human immunodeficiency virus vaccines.

Results: We found that there are several successful approaches to improving vaccine acceptance. Interventions should be context specific and build on the challenges highlighted in various settings.

Conclusion: Strategies could be used alone or in combination with others. The most successful interventions directly targeted the population for vaccination. Use of financial incentives could be a potential tool to improve vaccine uptake.

Keywords: COVID-19; Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Interventions; Measles; Vaccine hesitancy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines*
  • COVID-19* / prevention & control
  • HIV Infections* / prevention & control
  • Humans
  • Measles*
  • Papillomavirus Vaccines* / therapeutic use
  • Patient Acceptance of Health Care
  • Vaccination Hesitancy

Substances

  • AIDS Vaccines
  • Papillomavirus Vaccines